51
Participants
Start Date
July 21, 2004
Primary Completion Date
April 1, 2018
Study Completion Date
May 31, 2018
PANVAC-V
Patients receive 2 x 10(8) pfu PANVAC-V (vaccinia) subcutaneously on Day 1.
PANVAC-F
Patients receive 1 x 10(9) pfu PANVAC-F (fowlpox) or about days 15, 29, and 43 then every month for 12 doses then every 3 months until disease progression or toxicity.
Sargramostim (GM-CSF, Leukine)
100g sargramostim will be given subcutaneously at the site of the vaccination on each vaccination day and for three consecutive days thereafter.
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda
National Cancer Institute (NCI)
NIH